I've been thinking about this a bit more, and this may well be very significant...IF the FDA finds their reason to delay approval, Mexico's quick approval would then mean an "immediate" revenue stream. And the ability to crank up the production stream for Leronlimab. And likely entry into South America and elsewhere in the world, especially as more and more lives are saved. And then the pressure on the FDA...
To The Moon Aliuce